|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
198,760,000 |
Market
Cap: |
18.93(B) |
Last
Volume: |
1,868,399 |
Avg
Vol: |
1,246,896 |
52
Week Range: |
$76.72 - $102.77 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P SMALLCAP 600 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 949 |
Guru Rank Value : 0 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Cooper Companies is a medical device company. Co.'s business units are CooperVision and CooperSurgical. CooperVision develops, manufactures and markets a range of contact lenses. CooperVision designs its products for astigmatism, presbyopia, myopia, ocular dryness and eye fatigues, with a collection of spherical, toric and multifocal contact lenses. CooperVision also has access to myopia management and specialty eye care markets with other products, such as orthokeratology and scleral lenses. CooperSurgical focuses on improving the health of women, babies and families through a portfolio of products and services including medical devices, fertility, diagnostics and contraception.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
296,012 |
376,832 |
376,832 |
416,558 |
Total Sell Value |
$30,180,572 |
$59,400,182 |
$59,400,182 |
$72,826,453 |
Total People Sold |
2 |
3 |
3 |
5 |
Total Sell Transactions |
3 |
7 |
7 |
10 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kaufman Carol R |
EVP, Sec. & Chief Gov. Officer |
|
2017-06-08 |
4 |
S |
$242.26 |
$4,625,237 |
D/D |
(19,092) |
43,919 |
|
- |
|
Kaufman Carol R |
EVP, Sec. & Chief Gov. Officer |
|
2017-06-08 |
4 |
OE |
$13.10 |
$250,105 |
D/D |
19,092 |
63,011 |
|
- |
|
Kaufman Carol R |
EVP, Sec. & Chief Gov. Officer |
|
2017-06-07 |
4 |
S |
$242.67 |
$6,080,679 |
D/D |
(25,000) |
43,919 |
|
- |
|
Kaufman Carol R |
EVP, Sec. & Chief Gov. Officer |
|
2017-06-07 |
4 |
OE |
$13.10 |
$329,315 |
D/D |
25,000 |
68,919 |
|
- |
|
Zinberg Stanley Md |
Director |
|
2017-06-07 |
4 |
S |
$243.14 |
$198,400 |
I/I |
(816) |
0 |
|
- |
|
Zinberg Stanley Md |
Director |
|
2017-06-06 |
4 |
GA |
$0.00 |
$0 |
I/I |
816 |
816 |
|
- |
|
Zinberg Stanley Md |
Director |
|
2017-06-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
816 |
7,807 |
|
- |
|
Rubenstein Allan E |
Director |
|
2017-06-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
104 |
5,690 |
|
- |
|
Remmell Paul L |
Pres & CEO - CooperSurgical |
|
2017-04-04 |
4 |
S |
$199.99 |
$720,974 |
D/D |
(3,605) |
0 |
|
- |
|
Bender A Thomas |
Director |
|
2017-03-24 |
4 |
S |
$200.94 |
$301,405 |
D/D |
(1,500) |
11,478 |
|
- |
|
Remmell Paul L |
Pres & CEO - CooperSurgical |
|
2017-03-24 |
4 |
S |
$201.03 |
$376,823 |
D/D |
(1,871) |
3,605 |
|
- |
|
Rubenstein Allan E |
Director |
|
2017-03-23 |
4 |
S |
$200.00 |
$400,000 |
D/D |
(2,000) |
5,794 |
|
- |
|
Rubenstein Allan E |
Director |
|
2017-03-17 |
4 |
S |
$195.00 |
$346,125 |
D/D |
(1,775) |
7,794 |
|
- |
|
Rubenstein Allan E |
Director |
|
2017-03-17 |
4 |
OE |
$128.35 |
$227,821 |
D/D |
1,775 |
9,569 |
|
- |
|
Lindell Jody S |
Director |
|
2017-03-14 |
4 |
S |
$193.38 |
$966,916 |
I/I |
(5,000) |
9,833 |
|
- |
|
Lindell Jody S |
Director |
|
2017-03-14 |
4 |
OE |
$13.08 |
$65,400 |
I/I |
5,000 |
14,833 |
|
- |
|
Rubenstein Allan E |
Director |
|
2017-03-10 |
4 |
S |
$195.13 |
$346,349 |
D/D |
(1,775) |
7,794 |
|
- |
|
Rubenstein Allan E |
Director |
|
2017-03-10 |
4 |
OE |
$128.35 |
$227,821 |
D/D |
1,775 |
9,569 |
|
- |
|
Petersmeyer Gary S |
Director |
|
2017-03-09 |
4 |
S |
$194.19 |
$33,401 |
I/I |
(172) |
899 |
|
- |
|
Lindell Jody S |
Director |
|
2017-03-07 |
4 |
S |
$193.75 |
$969,189 |
I/I |
(5,000) |
9,833 |
|
- |
|
Lindell Jody S |
Director |
|
2017-03-07 |
4 |
OE |
$13.08 |
$65,400 |
I/I |
5,000 |
14,833 |
|
- |
|
Remmell Paul L |
Pres & CEO - CooperSurgical |
|
2017-02-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(765) |
5,476 |
|
- |
|
Remmell Paul L |
Pres & CEO - CooperSurgical |
|
2017-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,225 |
6,241 |
|
- |
|
White Albert G Iii |
EVP, CFO & CSO |
|
2017-02-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,230) |
35,395 |
|
- |
|
White Albert G Iii |
EVP, CFO & CSO |
|
2017-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,225 |
36,625 |
|
- |
|
1488 Records found
|
|
Page 15 of 60 |
|
|